S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
OTCMKTS:JAPAF

Japan Tobacco (JAPAF) Stock Price, News & Analysis

$26.32
0.00 (0.00%)
(As of 04/18/2024 ET)
Today's Range
$26.32
$26.32
50-Day Range
$25.41
$26.86
52-Week Range
$20.80
$26.86
Volume
N/A
Average Volume
510 shs
Market Capitalization
N/A
P/E Ratio
0.12
Dividend Yield
302.79%
Price Target
N/A
JAPAF stock logo

About Japan Tobacco Stock (OTCMKTS:JAPAF)

Japan Tobacco Inc., a tobacco company, manufactures and sells tobacco products, pharmaceuticals, and processed foods in Japan and internationally. The company operates through three segments: Tobacco Business, Pharmaceutical, and Processed Food. It offers tobacco products, such as cigarettes, heat-not-burn tobacco products, E-vapor products, fine cut tobacco products, cigars, pipes, smokeless tobacco products, and hookah and kretek products. The company also provides reduced-risk products, including infused tobacco capsules and heated tobacco sticks. In addition, it researches and develops, manufactures, and sells prescription drugs for the therapeutic areas, such as cardiovascular, kidney and metabolism, immunity/inflammation, and central nervous system. Further, the company provides frozen and room-temperature products, such as frozen udon noodles, packed rice, and frozen okonomiyaki; bakery products; and seasonings, including yeast extracts, assembled, kelp and bonito extracts, and oyster sauces. It offers its products under the Winston, Camel, MEVIUS, and LD brands. Japan Tobacco Inc. was incorporated in 1985 and is headquartered in Tokyo, Japan.

JAPAF Stock Price History

JAPAF Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
JAPAF Japan Tobacco Inc.
Japan Tobacco Inc (2914)
5 Largest Tobacco Companies in the World by Market Cap
JAPAF - Japan Tobacco Inc.
See More Headlines
Receive JAPAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Japan Tobacco and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Tobacco
Sub-Industry
N/A
Current Symbol
OTCMKTS:JAPAF
CIK
N/A
Fax
N/A
Employees
52,640
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Masamichi Terabatake (Age 59)
    President, CEO, President of Tobacco Business & Representative Director
    Comp: $2.74M
  • Mr. Hiromasa Furukawa
    Senior VP, CFO & Corporate Communications
  • Dinesh Babu Thotakura
    General Manager of Media & Investor Relations Division
  • Kenji Ogura
    Senior Vice President of Corporate Governance & Compliance
  • Osamu Hirose
    Senior VP & General Counsel
  • Mr. Kei Nakano (Age 56)
    EVP of Finance, Corporate Communications, Business Development & D-LAB and Representative Director
  • Mr. Koji Shimayoshi (Age 56)
    EVP of CS, Sustainability, People, Culture, IT, Legal, OR, BA, Pharma & Food Bus. and Rep. Director
  • Mr. Junichi Fukuchi
    SVP, CEO of Japanese Tobacco Business - Tobacco Business Planning - Tobacco Business
  • Mr. Muneaki Fujimoto
    Senior VP & President of Pharmaceutical Business
  • Mr. Hisashi Ishikawa
    VP & Head of Tobacco Business Planning Division

JAPAF Stock Analysis - Frequently Asked Questions

How have JAPAF shares performed in 2024?

Japan Tobacco's stock was trading at $26.1385 on January 1st, 2024. Since then, JAPAF shares have increased by 0.7% and is now trading at $26.3231.
View the best growth stocks for 2024 here
.

Are investors shorting Japan Tobacco?

Japan Tobacco saw a drop in short interest in March. As of March 31st, there was short interest totaling 95,300 shares, a drop of 28.4% from the March 15th total of 133,100 shares. Based on an average trading volume of 800 shares, the days-to-cover ratio is presently 119.1 days.
View Japan Tobacco's Short Interest
.

Is Japan Tobacco a good dividend stock?

Japan Tobacco (OTCMKTS:JAPAF) pays an annual dividend of $79.71 per share and currently has a dividend yield of 2.54%. The dividend payout ratio is 35.34%. This payout ratio is at a healthy, sustainable level, below 75%.

How do I buy shares of Japan Tobacco?

Shares of JAPAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:JAPAF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners